OMCL logo

OMCL
Omnicell, Inc.

753
Mkt Cap
$1.67B
Volume
349,997.00
52W High
$55.00
52W Low
$22.66
PE Ratio
841.90
OMCL Fundamentals
Price
$36.37
Prev Close
$36.65
Open
$36.91
50D MA
$36.88
Beta
0.87
Avg. Volume
623,898.57
EPS (Annual)
$0.0443
P/B
1.33
Rev/Employee
$330,962.29
$2,053.51
Loading...
Loading...
News
all
press releases
Wells Fargo & Company Forecasts Strong Price Appreciation for Omnicell (NASDAQ:OMCL) Stock
Wells Fargo & Company increased their target price on shares of Omnicell from $52.00 to $55.00 and gave the company an "overweight" rating in a research report on Thursday...
MarketBeat·17h ago
News Placeholder
More News
News Placeholder
Omnicell (OMCL) Projected to Post Earnings on Tuesday
Omnicell (NASDAQ:OMCL) will be releasing its Q1 2026 earnings before the market opens on Tuesday, April 28. (View Earnings Report at...
MarketBeat·3d ago
News Placeholder
Omnicell, Inc. (NASDAQ:OMCL) Receives Average Recommendation of "Moderate Buy" from Brokerages
Omnicell, Inc. (NASDAQ:OMCL - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the eight analysts that are covering the stock, Marketbeat.com reports. One investment...
MarketBeat·6d ago
News Placeholder
OPRX Trades at a Discount to Industry: How to Approach the Stock Now?
OptimizeRx trades at a steep discount to peers, but strong AI-driven growth, rising cash flow and DAAP traction look encouraging.
Zacks·7d ago
News Placeholder
Omnicell to Release First Quarter 2026 Financial Results on April 28, 2026
Omnicell, Inc. (Nasdaq:OMCL), a leading healthcare technology provider focused on empowering autonomous medication management, will release its financial results for the first quarter 2026, before market open on Tuesday, April 28, 2026. The Company will host a conference call and webcast to discuss...
Business Wire·10d ago
News Placeholder
TEM Stock Gains 17.9% in a Year: Time to Buy, Hold or Sell?
Tempus AI rides on diagnostics growth, AI-driven data demand, and pricing gains - but persistent losses and valuation questions complicate the buy-or-sell call.
Zacks·15d ago
News Placeholder
Do Options Traders Know Something About Omnicell Stock We Don't?
Investors need to pay close attention to OMCL stock based on the movements in the options market lately.
Zacks·16d ago
News Placeholder
Assenagon Asset Management S.A. Has $11.70 Million Stake in Omnicell, Inc. $OMCL
Assenagon Asset Management S.A. increased its holdings in shares of Omnicell, Inc. (NASDAQ:OMCL - Free Report) by 83.6% during the fourth quarter, according to its most recent Form 13F filing with...
MarketBeat·27d ago
News Placeholder
JPMorgan Chase & Co. Has $15.69 Million Position in Omnicell, Inc. $OMCL
JPMorgan Chase & Co. cut its position in Omnicell, Inc. (NASDAQ:OMCL - Free Report) by 94.2% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange...
MarketBeat·28d ago
News Placeholder
Should You Continue to Hold OMCL Stock in Your Portfolio?
Omnicell's autonomous pharmacy push and SaaS growth show promise, but rising costs and weak hospital spending cloud its near-term outlook.
Zacks·1mo ago
<
1
2
...
>

Latest OMCL News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.